Shrinidhi Nathany: Why the Theriome Matters More Than We Think
Shrinidhi Nathany, Consultant Molecular Hematology and Oncology at Fortis Memorial, posted on LinkedIn:
“Sunday learning with the boss Dr. Rahul Bhargava
After a break back with a bang.. with more new concepts
As i started a thread on theriome, i will continue that today
Why the Theriome Matters More Than We Think
We often ask why patients with the same diagnosis and similar mutations have very different outcomes.
The answer often lies in the theriome.
The theriome influences how aggressively a tumour behaves, how it escapes the immune system and how it responds or fails to respond to therapy. In hematologic malignancies, the bone marrow and lymphoid niche can actively protect malignant cells from chemotherapy and targeted drugs.
This is why genomics alone is sometimes not enough. To truly understand cancer behaviour, we must also understand the ecosystem in which the cancer lives.”
Stay informed with Hemostasis Today.
-
Sep 17, 2026, 03:04Leonardo Roever: Exploring the Role of Glutamine Metabolism in Atherosclerosis
-
Sep 17, 2026, 02:36Wolfgang Miesbach: Effectiveness of Avatrombopag in ITP Treatment
-
Sep 17, 2026, 02:34Aleksandar Sič: The Endothelium and Cardiovascular Toxicity in Blood Cancers
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research